This inventor holds 1 USPTO granted patent. Top assignee: Nanjing University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations of Hongwei Liang in Cancer Treatment
Introduction
Hongwei Liang is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on the application of RNA interference technology to combat various types of cancers.
Latest Patents
Hongwei Liang holds a patent titled "MULTI-TARGETED siRNA FOR TREATING CANCERS." This patent represents a breakthrough in targeted cancer therapies, showcasing his commitment to advancing medical science and improving patient outcomes. He has 1 patent to his name, reflecting his dedication to innovation in this critical area.
Career Highlights
Hongwei Liang is affiliated with Nanjing University, where he conducts research and collaborates with fellow scientists. His academic background and expertise in molecular biology have positioned him as a key figure in cancer research. His work has garnered attention for its potential to revolutionize treatment options for patients suffering from cancer.
Collaborations
He has collaborated with notable colleagues, including Jing Li and Zheng Fu. These partnerships have enhanced his research efforts and contributed to the development of effective cancer therapies.
Conclusion
Hongwei Liang's contributions to cancer treatment through his innovative patent and collaborative efforts highlight his role as a leading inventor in the field. His work continues to inspire advancements in medical research and offers hope for improved cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile